Emcure Pharmaceuticals has informed that pursuant to the Code of Conduct for regulating, monitoring and reporting of insider trading in the securities of the Company, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading window for trading/ dealing in securities of the Company by the Designated Persons and their immediate relatives will be closed with effect from Tuesday, October 01, 2024, and shall remain closed up to 48 hours after the declaration of the unaudited financial results of the Company for the quarter and half-year ending on September 30, 2024. The date of the Board Meeting for consideration and approval of the unaudited financial results of the Company for the quarter and half-year ending on September 30, 2024, shall be intimated in due course.
The above information is a part of company’s filings submitted to BSE.